+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Guillain-Barre Syndrome Diagnostics Market Size, Share & Trends Report by Test (Lumbar Puncture, Electromyography), End-Use (Hospitals and Clinics, Diagnostic Laboratories), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6056041
Description Jump to:
The Guillain-Barre Syndrome Diagnostics Market was valued at USD 144.5 million in 2024, and is projected to reach USD 169.9 million by 2030, rising at a CAGR of 2.80%. driven by several key factors. A significant contributor is the increasing incidence of Guillain-Barre syndrome (GBS), particularly in regions with high rates of infectious diseases. Infections such as respiratory or gastrointestinal illnesses often precede GBS, leading to a heightened demand for effective diagnostic tools. For instance, a study from the University of Minnesota in October 2023 highlighted that 67% of GBS cases were preceded by such infections, underscoring the need for timely diagnosis.

Advancements in diagnostic techniques have also played a crucial role in market expansion. Innovations in electromyography (EMG) and nerve conduction studies have enhanced the accuracy and speed of GBS diagnosis. These technological improvements enable healthcare professionals to detect the syndrome earlier, facilitating prompt intervention and better patient outcomes. The integration of advanced diagnostic tools in clinical settings has become increasingly prevalent, reflecting a commitment to improving patient care.

The growing awareness of GBS among healthcare providers and the general population has further propelled the diagnostics market. Educational initiatives and increased information dissemination have led to earlier recognition of symptoms and subsequent diagnostic testing. This heightened awareness ensures that patients receive timely and appropriate care, reducing the risk of severe complications associated with delayed diagnosis. Consequently, the demand for diagnostic services has risen, contributing to market growth.

The expanding geriatric population has influenced the market for GBS diagnostics. Older individuals are more susceptible to infections that can trigger GBS, necessitating effective diagnostic measures. According to the World Health Organization's 2021 forecast, by 2030, one in six individuals worldwide will be over 60, with their numbers expected to grow from 1 billion in 2020 to 2.1 billion by 2050. This demographic shift underscores the importance of accessible and accurate diagnostic tools to manage the anticipated increase in GBS cases among the elderly.

Key players in the market are implementing strategic initiatives such as geographical expansion, collaborations, partnerships, and joint ventures to strengthen their market presence.

Guillain-Barre Syndrome Diagnostics Market Report Highlights

  • The test segment of the market includes lumbar puncture, electromyography, nerve conduction studies, and others. The lumbar puncture segment led the market in 2024, accounting for the largest revenue share of 45.1%, and is expected to experience the fastest compound annual growth rate (CAGR) of 3.0% during the forecast period, driven by its essential role in confirming GBS diagnosis.
  • The end-use segment comprises hospitals & clinics, and diagnostic laboratories. In 2024, the hospitals & clinics segment led the market, capturing a revenue share of 63.0%, driving significant growth through the integration of advanced diagnostic tools and improved patient management protocols.
  • Asia Pacific dominated the global market with a revenue share of 41.8% in 2024. Factors such as rising awareness, improving healthcare infrastructure, and increasing diagnostic rates are driving market expansion.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Guillain-Barre Syndrome (GBS) Diagnostics Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.1.3. Market opportunities analysis
3.2. Guillain-Barre Syndrome (GBS) Diagnostics Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. COVID-19 Impact Analysis
3.2.4. Case Studies
Chapter 4. Guillain-Barre Syndrome (GBS) Diagnostics Market: Test Estimates & Trend Analysis
4.1. Test Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Guillain-Barre Syndrome (GBS) Diagnostics Market by Product Test Outlook
4.4. Lumbar Puncture
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Nerve Conduction Studies
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Electromyography
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Guillain-Barre Syndrome (GBS) Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Guillain-Barre Syndrome (GBS) Diagnostics Market by End Use Outlook
5.4. Hospitals and Clinics
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Diagnostic Laboratories
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Guillain-Barre Syndrome (GBS) Diagnostics Market: Regional Estimates & Trend Analysis, by Product, by Test, by End Use
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share/position analysis, 2024
7.4. Company Profiles
7.4.1. Cadwell Industries, Inc
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Technology test benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Natus Medical Incorporated
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Technology test benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Nihon Kohden Corporation
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Technology test benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Medtronic plc
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Technology test benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Bionen Medical Devices
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Technology test benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Deymed Diagnostic
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Technology test benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Neurosoft
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Technology test benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Alpine Biomed
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Technology test benchmarking
7.4.8.4. Strategic initiatives
7.4.9. EMS Biomedical
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Technology test benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Rochester Electro-Medical, Inc
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Technology test benchmarking
7.4.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 4 North America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 5 U.S. Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 6 U.S. Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 7 Canada Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 8 Canada Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 9 Mexico Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 10 Mexico Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 11 Europe Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 12 Europe Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 13 UK Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 14 UK Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 15 Germany Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 16 Germany Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 17 France Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 18 France Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 19 Italy Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 20 Italy Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 21 Spain Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 22 Spain Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 23 Denmark Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 24 Denmark Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 25 Sweden Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 26 Sweden Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 27 Norway Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 28 Norway Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 29 Asia Pacific Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 30 Asia Pacific Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 31 Japan Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 32 Japan Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 33 China Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 34 China Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 35 India Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 36 India Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 37 Australia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 38 Australia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 39 South Korea Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 40 South Korea Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 41 Thailand Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 42 Thailand Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 43 Latin America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 44 Latin America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 45 Brazil Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 46 Brazil Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 47 Argentina Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 48 Argentina Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 49 MEA Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 50 MEA Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 51 South Africa Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 52 South Africa Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 53 Saudi Arabia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 54 Saudi Arabia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 55 UAE Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 56 UAE Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
Table 57 Kuwait Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018-2030 (USD Million)
Table 58 Kuwait Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Guillain-Barre Syndrome (GBS) Diagnostics market outlook
Figure 9 Guillain-Barre Syndrome (GBS) Diagnostics competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Guillain-Barre Syndrome (GBS) Diagnostics market driver impact
Figure 15 Guillain-Barre Syndrome (GBS) Diagnostics market restraint impact
Figure 16 Guillain-Barre Syndrome (GBS) Diagnostics market strategic initiatives analysis
Figure 17 Guillain-Barre Syndrome (GBS) Diagnostics market: Test analysis
Figure 18 Guillain-Barre Syndrome (GBS) Diagnostics market: Test outlook and key takeaways
Figure 19 Clinical writing market estimates and forecast, 2018-2030
Figure 20 Lumbar puncture market estimates and forecast, 2018-2030
Figure 21 Nerve conduction studies market estimates and forecast, 2018-2030
Figure 22 Electromyography market estimates and forecast, 2018-2030
Figure 23 Others market estimates and forecast, 2018-2030
Figure 24 Guillain-Barre Syndrome (GBS) Diagnostics market: End use movement analysis
Figure 25 Guillain-Barre Syndrome (GBS) Diagnostics market: End use outlook and key takeaways
Figure 26 Hospitals and clinics market estimates and forecast, 2018-2030
Figure 27 Diagnostic laboratories market estimates and forecast, 2018-2030
Figure 28 Global Guillain-Barre Syndrome (GBS) Diagnostics market: Regional movement analysis
Figure 29 Global Guillain-Barre Syndrome (GBS) Diagnostics market: Regional outlook and key takeaways
Figure 30 Global Guillain-Barre Syndrome (GBS) Diagnostics market share and leading players
Figure 31 North America market share and leading players
Figure 32 Europe market share and leading players
Figure 33 Asia Pacific market share and leading players
Figure 34 Latin America market share and leading players
Figure 35 Middle East & Africa market share and leading players
Figure 36 North America: SWOT
Figure 37 Europe SWOT
Figure 38 Asia Pacific SWOT
Figure 39 Latin America SWOT
Figure 40 MEA SWOT
Figure 41 North America market estimates and forecasts, 2018-2030
Figure 42 U.S. market estimates and forecasts, 2018-2030
Figure 43 Canada market estimates and forecasts, 2018-2030
Figure 44 Mexico market estimates and forecasts, 2018-2030
Figure 45 Europe market estimates and forecasts, 2018-2030
Figure 46 UK market estimates and forecasts, 2018-2030
Figure 47 Germany market estimates and forecasts, 2018-2030
Figure 48 France market estimates and forecasts, 2018-2030
Figure 49 Italy market estimates and forecasts, 2018-2030
Figure 50 Spain market estimates and forecasts, 2018-2030
Figure 51 Denmark market estimates and forecasts, 2018-2030
Figure 52 Sweden market estimates and forecasts, 2018-2030
Figure 53 Norway market estimates and forecasts, 2018-2030
Figure 54 Asia Pacific market estimates and forecasts, 2018-2030
Figure 55 China market estimates and forecasts, 2018-2030
Figure 56 Japan market estimates and forecasts, 2018-2030
Figure 57 India market estimates and forecasts, 2018-2030
Figure 58 Thailand market estimates and forecasts, 2018-2030
Figure 59 South Korea market estimates and forecasts, 2018-2030
Figure 60 Australia market estimates and forecasts, 2018-2030
Figure 61 Latin America market estimates and forecasts, 2018-2030
Figure 62 Brazil market estimates and forecasts, 2018-2030
Figure 63 Argentina market estimates and forecasts, 2018-2030
Figure 64 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 65 South Africa market estimates and forecasts, 2018-2030
Figure 66 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 67 UAE market estimates and forecasts, 2018-2030
Figure 68 Kuwait market estimates and forecasts, 2018-2030
Figure 69 Market share of key market players- Guillain-Barre Syndrome (GBS) Diagnostics market
Figure 70 Key Company Categorization
Figure 71 Company Market Share/Position Analysis, 2024
Figure 72 Strategic Framework

Companies Mentioned

The major companies profiled in this Guillain-Barre Syndrome Diagnostics market report include:
  • Cadwell Industries, Inc
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Medtronic plc
  • Bionen Medical Devices
  • Deymed Diagnostic
  • Neurosoft
  • Alpine Biomed
  • EMS Biomedical
  • Rochester Electro-Medical, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 144.5 Million
Forecasted Market Value ( USD ) by 2030 $ 169.9 Million
Compound Annual Growth Rate2.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutic (Intravenous Immunoglobulin (IVIG)), By Type (AIDP), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutic (Intravenous Immunoglobulin (IVIG)), By Type (AIDP), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Guillain-Barre Syndrome Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Guillain-Barre Syndrome Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Guillain-Barre Syndrome (GBS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Guillain-Barre Syndrome (GBS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Guillain-Barre Syndrome Market by Type, Treatment, End-User - Global Forecast 2025-2030 - Product Image

Guillain-Barre Syndrome Market by Type, Treatment, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025 - Product Image

Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.